Dissemin is shutting down on January 1st, 2025

Links

Tools

Export citation

Search in Google Scholar

Pembrolizumab (oesophageal cancer) - Benefit assessment

Report published in 2022 by Philip Böhler ORCID, Philip Böhler
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload